Our recent studies found that Aur-A activates mammalian target of rapamycin (mTOR) pathway in breast cancer cell models and inhibits autophagy activity, which is not dependent on the classical PI3K-AKT1 pathway29. This evidence concerns the gene MTOR and breast carcinoma.